Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Acute asthma treatment with levalbuterol in the ED resulted in higher patient discharge rates
February 8th, 2006
Study finds acute asthma treatment with levalbuterol in the emergency department resulted in higher patient discharge rates. According to a study from the United States, "Acute asthma is often treated with racemic albuterol, a 1:1 mixture of (R)-albuterol and (S)-albuterol. Levalbuterol is the single-isomer agent comprised (R)-albuterol, an active bronchodilator, without any effects of (S)-albuterol." D.M. Schreck and colleagues, Summit Medical Group wrote that the purpose of their study was, "To compare emergency department (ED) admission rates of patients presenting with acute asthma who were treated with either racemic albuterol or levalbuterol."...
Source: Immunotherapy Weekly (2006-02-08)
|
